Skip to Main Content

COVID-19 is an emerging, rapidly evolving situation.

What people with cancer should know: https://www.cancer.gov/coronavirus

Get the latest public health information from CDC: https://www.coronavirus.gov

Get the latest research information from NIH: https://www.nih.gov/coronavirus

Results: 37 (Showing 31 to 35)

PLCO EEMS Round 21 is closed to preliminary applications. Full applications remain open for individuals with approved preliminary applications.

Full applications will only be accepted until March 1, 2016. To access your full applications, you must login to CDAS. The deadline for PLCO EEMS preliminary applications was January 3, 2016. Please check CDAS for updates on the next round of PLCO EEMS proposal review. If you have any questions about project feasibility and specimen availability for future EEMS rounds, please contact CDAS staff at cdas-eems@imsweb.com.

PLCO EEMS Round 21 is now open for preliminary applications
Posted by CDAS Administrator on Dec. 1, 2015, noon in PLCO

Preliminary applications will only be accepted until January 3, 2016. If you plan to submit an EEMS application this cycle, an approved preliminary application is required. Please note that this has changed from previous application cycles. Once your preliminary application has been approved, you will be notified and you will be able to continue and submit a full application. The deadline for full application submission is March 1, 2016.

Information is available regarding the PLCO trial and PLCO biospecimens.

Please visit the EEMS Application for Biospecimens page to preview instructions about the process, review the EEMS Policies and Procedures, and begin an EEMS Preliminary Application for Biospecimens.

Due to administrative factors, the timeline for this review cycle may be subject to change. If you have any questions, please contact CDAS staff at cdas-eems@imsweb.com.

Preliminary applications will only be accepted until January 18, 2016. If you plan to submit a PAR-15-297 grant application this cycle, an approved preliminary grant application is required. Please note that this has changed from previous application cycles.

Information is available regarding the PLCO trial and PLCO biospecimens.

Please visit the PAR Preliminary Application for Biospecimens and Funding page to preview instructions about the process, review the EEMS Policies and Procedures, and begin a PAR Preliminary Application for Biospecimens and Funding.

Due to administrative factors, the timeline for this review cycle may be subject to change. If you have any questions, please contact CDAS staff at cdas-eems@imsweb.com.

PLCO EEMS Round 21 will begin accepting preliminary applications in December 2015
Posted by CDAS Administrator on Nov. 2, 2015, midnight in PLCO

Preliminary applications for PLCO EEMS Round 21 will only be accepted from approximately December 1, 2015, through January 3, 2016. If you plan to submit an EEMS application this cycle, an approved preliminary application is required. Please note that this has changed from previous application cycles. Once your preliminary application has been approved, you will be notified and you will be able to continue and submit a full application. The deadline for full application submission is March 1, 2016.

Information is available regarding the PLCO trial and biospecimens.

Due to administrative factors and uncertainty in website development, the timeline for the release of the preliminary application and upcoming review cycle will be subject to changes. Please check CDAS frequently for an updated timeline. If you have any questions, please contact CDAS staff at cdas-eems@imsweb.com.

Preliminary applications will only be accepted from approximately December 1, 2015, through January 18, 2016.If you plan to submit a grant application this cycle, an approved preliminary grant application is required. Please note that this has changed from previous application cycles. Once your preliminary grant application has been approved, you will receive a confirmation letter to accompany your grant application.

Information is available regarding the PLCO trial and biospecimens.

Due to administrative factors and uncertainty in website development, the timeline for the release of the preliminary application and upcoming review cycle will be subject to changes. Please check CDAS frequently for an updated timeline. If you have any questions, please contact CDAS staff at cdas-eems@imsweb.com.